Measuring colorectal cancer care quality for the publicly insured in New York State

Cancer Medicine

Volumn 1, Issue 3, 2012, Pages 363-371

  Sinclair, Amber H ^a   Schymura, Maria J ^a   Boscoe, Francis P ^a   Yung, Rachel L ^b   Chen, Kun ^b   Roohan, Patrick ^a   Tai, Eric ^c   Schrag, Deborah ^b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Colorectal cancer; Guideline adherence; Medicaid; Medicare; Quality of care

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BILLING AND CLAIMS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; RACE DIFFERENCE; UNITED STATES;

EID: 84888376222     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.30     Document Type: Article

References (25)

1. U.S. Centers for Disease Control and Prevention. 2012. National Program of Cancer Registries. United States Cancer Statistics. Available at http://apps.nccd.cdc.gov/uscs/toptencancers.aspx (accessed 18 January 2012).
2. New York State Cancer Registry. 2011. Cancer incidence and mortality, 2004-2008, New York State. New York State Department of Health. Available at http://www.health.state.ny.us/statistics/cancer/registry/vol1/v1rnys.htm (accessed 28 April 2011).
3. ASCO. 2011. Progress against colorectal cancer. Available at www.cancerprogress.net (accessed 27 July 2011).
4. ASCO. 2007. ASCO/NCCN quality measures: breast and colorectal cancers. Available at www.asco.org/qualitymeasures (accessed 28 July 2011).
5. Desch, C. E., K. K. McNiff, E. C. Schneider, D. Schrag, J. McClure, E. Lepisto, et al. 2008. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J. Clin. Oncol. 26:3631-3637.
6. Romanus, D., M. R. Weiser, J. M. Skibber, A. Ter Veer, J. C. Niland, J. L. Wilson, et al. 2009. Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: an NCCN institutional analysis. J. Natl. Compr. Cancer Netw. 7:895-904.
7. Institute of Medicine. 2000. Enhancing data systems to improve the quality of cancer care. National Academies Press, Washington, DC.
8. Institute of Medicine and National Research Council. 2005. Assessing the quality of cancer care: an approach to measurement in Georgia. National Academies Press, Washington, DC.
9. Schrag, D., L. D. Cramer, P. B. Bach, and C. B. Begg 2001. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J. Natl. Cancer Inst. 93:850-857.
10. Kahn, K. L., J. L. Adams, J. C. Weeks, E. A. Chrischilles, D. Schrag, J. Z. Ayanian, et al. 2010. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 303:1037-1045.
11. Cooper, G. S., T. D. Kou, and H. L. Reynolds 2008. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer 113:2029-2037.
12. Potosky, A. L., L. C. Harlan, R. S. Kaplan, K. A. Johnson, and C. F. Lynch 2002. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J. Clin. Oncol. 20:1192-1202.
13. Berry, J., L. Caplan, S. Davis, P. Minor, M. Counts-Spriggs, R. Glover, et al. 2010. A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer 116:713-722.
14. Ayanian, J. Z., A. M. Zaslavsky, C. S. Fuchs, E. Guadagnoli, C. M. Creech, R. D. Cress, et al. 2003. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J. Clin. Oncol. 21:1293-1300.
15. Bradley, C. J., C. W. Given, B. Dahman, and T. L. Fitzgerald 2008. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch. Intern. Med. 168:521-529.
16. Cress, R. D., S. A. Sabatino, X. Wu, M. J. Schymura, R. Rycroft, E. Stuckart, et al. 2009. Adjuvant chemotherapy for patients with Stage III colon cancer: results from a CDC-NPCR patterns of care study. Clin. Med. Oncol. 3:107-119.
17. Demissie, K., O. O. Oluwole, B. A. Balasubramanian, O. O. Osinubi, D. August, and G. G. Rhoads 2004. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between blacks and whites. Ann. Epidemiol. 14:215-221.
18. White, A., C. C. Liu, R. Xia, K. Burau, J. Cormier, W. Chan, et al. 2008. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer 113:3400-3409.
19. Roetzheim, R. G., N. Pal, E. C. Gonzalez, J. M. Ferrante, D. J. Van Durme, and J. P. Krischer 2000. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am. J. Public Health 90:1746-1754.
20. Institute of Medicine. 2003. Unequal treatment: confronting racial and ethnic disparities in healthcare. Institute of Medicine of the National Academies Press, Washington, DC.
21. Boscoe, F. P., D. Schrag, K. Chen, P. J. Roohan, and M. J. Schymura 2011. Building capacity to assess cancer care in the Medicaid Population in New York State. Health Serv. Res. 46:805-820.
22. Charlson, M. E., P. Pompei, K. I. Ales, and C. R. MacKenzie 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
23. Deyo, R. A., D. C. Cherkin, and M. A. Ciol 1992. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45:613-9.
24. Klabunde, C. N., A. L. Potosky, J. M. Legler, and J. L. Warren 2000. Development of a comorbidity index using physician claims data. J. Clin. Epidemiol. 53:1258-1267.
25. Berry, J., K. Bumpers, V. Ogunlade, R. Glover, S. Davis, M. Counts-Spriggs, et al. 2009. Examining racial disparities in colorectal cancer care. J. Psychosoc. Oncol. 27:59-83.